...daltons," Jhoti said. "In the past 10 to 15 years of high throughput screening and combichem...

...programs in cancer is a key step in ArQule Inc. 's continued transformation from one-time combichem...

...result, they are designed to provide the benefits of small molecules generated by high throughput combichem...

...Acquirer Date Acquired Value Assets Value chain segment DuPont Pharma (now part of Bristol-Myers) 1999 CombiChem...

...is accelerated. The results provide us with ideas about structure-affinity relationships, and we then use combichem...

...of five takeover moves since 1999. Very much farther down the food chain is onetime combichem...

...pharmacology, toxicology and kinetic studies, and is starting preclinical development. The company also built a combichem...

...infrastructure that it couldn't support. In 2002, it acquired the assets of combinatorial chemistry provider CombiChem Inc....

...of BMY’s Bristol-Myers Squibb Pharma Research Labs L.L.C. subsidiary (San Diego, Calif.), formerly known as CombiChem...

...Deltagen Inc. 's acquisition of Bristol-Myers Squibb Pharma Research Labs L.L.C., formerly CombiChem Inc. , which was...
...its transition from a gene knockout specialist through lead optimization. DGEN was able to buy CombiChem...
...had purchased CombiChem in 1999 for $95 million in stock (see BioCentury, Oct. 11, 1999). CombiChem...